The rare diseases treatment market is emerging as a critical area within the global pharmaceutical industry, with rapid advancements in research and therapy development. Rare diseases, also known as orphan diseases, affect a relatively small percentage of the population, but their impact on patients and healthcare systems is profound. As medical re